JM

Joan Monaco

Field Operations Manager at Boston Heart Diagnostics

Joan Monaco has a diverse work experience in the healthcare industry. Joan most recently worked at Lawrence General Hospital as a Laboratory Outreach Operations Supervisor starting in January 2021. Prior to that, they held the position of Manager, Laboratory Support Services at Catholic Medical Center starting in March 2017. Before that, they worked as a Field Operations Manager at Boston Heart Diagnostics starting in December 2014. Joan also has managerial experience at Milford Regional Medical Center as a Manager, Laboratory Support Services and Outreach starting in April 2012. Joan briefly worked as a Supervisor in the Central Processing Department at MetroWest Medical Center in April 2016. From 2009 to 2012, Joan served as an Outreach Account Manager at UMass Memorial Healthcare. Additionally, they worked at Milford Regional Medical Center from 2005 to 2008 and at Charles River Medical Associates as a Labcorp, Inc from 2000 to 2005.

Joan Monaco attended Assumption University from 1976 to 1980, where they obtained a Bachelor's degree in Biology, General. Joan also earned a Bachelor of Science (BS) degree in Biology during the same period of time.

Location

Boston, United States

Links


Org chart


Teams

This person is not in any teams


Offices


Boston Heart Diagnostics

Boston Heart Lab is a healthcare company that provides cardiovascular disease (CVD) management. Through there combination of proprietary lipid testing capability, sophisticated tools, advanced therapy guidelines, and patient support services, they are providing physicians, patients, and pharmaceutical companies with viable disease management.Unlike other lipid testing companies that are focused on the primary screening market for CVD, their proprietary testing technology allows for the ongoing monitoring of a patient's disease and precise determination of the most appropriate pharmaceutical alternatives. They can provide unique, personalized treatment options to patients with dyslipidemia to determine the efficacy of lipid adjusting drugs in most cases within the first 6 weeks of treatment. Competing methods usually need 6 months.